Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

Tumor buster - where will the CAR-T cell therapy ‘missile’ go?

Abstract Chimeric antigen receptor (CAR) T cell (CAR-T cell) therapy based on gene editing technology represents a significant breakthrough in personalized immunotherapy for human cancer. This strategy uses genetic modification to enable T cells to target tumor-specific antigens, attack specific can...

Full description

Bibliographic Details
Main Authors: Chunrun Qu, Hao Zhang, Hui Cao, Lanhua Tang, Haoyang Mo, Fangkun Liu, Liyang Zhang, Zhenjie Yi, Lifu Long, Luzhe Yan, Zeyu Wang, Nan Zhang, Peng Luo, Jian Zhang, Zaoqu Liu, Weijie Ye, Zhixiong Liu, Quan Cheng
Format: Article
Language:English
Published: BMC 2022-10-01
Series:Molecular Cancer
Subjects:
CAR-T cell
Immunotherapy
Target
Cancer
Personalized treatment
Online Access:https://doi.org/10.1186/s12943-022-01669-8

Internet

https://doi.org/10.1186/s12943-022-01669-8

Similar Items